Nevertheless, one can in contrast hypothesize that potentially lower rates of secreted netrin-1 as a result of sorafenib treatment may improve netrin’s neutralization rates and therefore further affect global survival of the tumor. The gene discussed is NTN1; the disease is neoplasm.